Why the study?
Polycystic ovary syndrome is commonly accompanied by insulin resistance, but its specific pathogenesis remains unclear, prompting investigation into the efficacy and mechanism of Jiawei Huanglian-Wendan decoction.
Does Jiawei Huanglian-Wendan decoction improve clinical syndromes and metabolic markers in patients with polycystic ovary syndrome and insulin resistance?
Population
Patients with polycystic ovary syndrome with insulin resistance
Comparison
Jiawei Huanglian-Wendan decoction
Design
Network pharmacology study with clinical validation
Authors
Loading...
May support JHWD evaluation in PCOS-IR; hypothesis-generating and requires RCTs before practice change.
Does Jiawei Huanglian-Wendan decoction improve clinical syndromes and metabolic markers in patients with polycystic ovary syndrome and insulin resistance?
Network pharmacology and clinical validation suggest that Jiawei Huanglian-Wendan decoction may regulate glycolipid metabolism, reduce insulin resistance, and exert anti-inflammatory effects in PCOS with IR.
Shi et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: